BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7890279)

  • 1. Intratumoral activation of CD8-positive cytotoxic lymphocytes in acquired immunodeficiency syndrome lymphomas.
    Devergne O; Raphael M; Autran B; Leger-Ravet MB; Coumbaras J; Crevon MC; Galanaud P; Emilie D
    Hum Pathol; 1995 Mar; 26(3):284-90. PubMed ID: 7890279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ detection of activated cytotoxic cells in follicular lymphomas.
    Leger-Ravet MB; Devergne O; Peuchmaur M; Solal-Celigny P; Brousse N; Gaulard P; Galanaud P; Emilie D
    Am J Pathol; 1994 Mar; 144(3):492-9. PubMed ID: 7510456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
    Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.
    Cherin P; Herson S; Crevon MC; Hauw JJ; Cervera P; Galanaud P; Emilie D
    J Rheumatol; 1996 Jul; 23(7):1135-42. PubMed ID: 8823683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cytotoxic molecules in intestinal T-cell lymphomas. The German Study Group on Intestinal Non-Hodgkin Lymphoma.
    Daum S; Foss HD; Anagnostopoulos I; Dederke B; Demel G; Araujo I; Riecken EO; Stein H
    J Pathol; 1997 Jul; 182(3):311-7. PubMed ID: 9349234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
    Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
    Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
    Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
    Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
    Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma.
    Foss HD; Demel G; Anagnostopoulos I; Araujo I; Hummel M; Stein H
    Pathobiology; 1997; 65(2):83-90. PubMed ID: 9253032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.
    Kumar S; Krenacs L; Medeiros J; Elenitoba-Johnson KS; Greiner TC; Sorbara L; Kingma DW; Raffeld M; Jaffe ES
    Hum Pathol; 1998 Apr; 29(4):397-403. PubMed ID: 9563791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: a possible mechanism of immune evasion in chronic active EBV infection.
    Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
    Pathol Int; 1999 Jan; 49(1):9-13. PubMed ID: 10227719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity.
    Mukai HY; Hasegawa Y; Kojima H; Okoshi Y; Takei N; Yamashita Y; Nagasawa T; Mori N
    Mod Pathol; 2002 Nov; 15(11):1131-9. PubMed ID: 12429791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents.
    Haridas V; McCloskey TW; Pahwa R; Pahwa S
    AIDS; 2003 Nov; 17(16):2313-22. PubMed ID: 14571182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of cytotoxic molecules in CD8- and/or CD56-positive adult T-cell leukaemia/lymphoma.
    Ohshima K; Haraoka S; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):101-4. PubMed ID: 10599307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?
    Ng CS; Lo ST; Chan JK; Chan WC
    Hum Pathol; 1997 Nov; 28(11):1276-82. PubMed ID: 9385933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
    Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
    Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
    Chiang AK; Chan AC; Srivastava G; Ho FC
    Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.